Delivery Order SPE2DB25D7068-SPE2DB25FTYCY
- Not listed
- The Defense Logistics Agency awarded a $1,961.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of September 4, 2025. This non-competitive delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,954.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $2,331.42 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $15,548.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,339.39 to AmerisourceBergen Drug Corp for ENGERIX-B 20 mcg/mL syringes, with an ultimate completion date of September 22, 2025. This non-competitive delivery order represents a firm fixed-price procurement issued under the company's existing indefinite delivery contract framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for federal medical...
- The Defense Logistics Agency (DLA) awarded a $3,312.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of September 8, 2025. This non-set-aside award represents a competitively awarded transaction under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,920.10 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price, competitively awarded contract was issued on September 2, 2025, with a completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,030.56 for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion deadline of July 31, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's broader federal contract portfolio supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $24,284.58 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, was competitively awarded without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the...
- The Defense Logistics Agency awarded a $28,321.00 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of July 30, 2025. This competitive, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTYCYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,102.28 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. The contract employs firm fixed price terms with an ultimate completion date of September 25, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support is concurrently planning Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, demonstrating the agency's strategic approach to leveraging multiple contractors for comprehensive pharmaceutical support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/24/25 |